Clinical Trial

Early Recurrence After Surgery for Pancreatic Cancer

Study acronym: POCEMON BLUE
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about early recurrence after curative-intent surgery for pancreatic cancer. The main questions it aims to answer are: * How often does early recurrence (within 12 months after surgery) occur? * When does it happen, and at which anatomical sites (liver, lung, local, peritoneum)? * How is recurrence detected (imaging or tumor markers)? Adults with histologically confirmed pancreatic ductal adenocarcinoma who undergo curative-intent resection without distant metastases will be enrolled. Participants will be followed according to routine clinical care at each hospital, typically with imaging and CA19-9 blood tests. No study-specific interventions are required.
Trial Details
NCT Number NCT07241676
Lead Sponsor Azienda Ospedaliera di Padova
Conditions Pancreatic Ductal Adenocarcinoma (PDAC), Recurrent Pancreatic Adenocarcinoma
Enrollment 500 participants
Start Date 2025-10-23
Primary Completion 2026-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-21